Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 18 03:08PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-1.64 Insider Own70.83% Shs Outstand30.06M Perf Week-15.04%
Market Cap11.16M Forward P/E- EPS next Y-0.58 Insider Trans0.00% Shs Float8.78M Perf Month-31.24%
Income-49.02M PEG- EPS next Q-0.23 Inst Own5.53% Short Float1.14% Perf Quarter18.44%
Sales27.51M P/S0.41 EPS this Y52.44% Inst Trans-12.74% Short Ratio0.13 Perf Half Y-60.99%
Book/sh0.01 P/B46.79 EPS next Y25.64% ROA-62.89% Short Interest0.10M Perf Year-87.56%
Cash/sh0.64 P/C0.58 EPS next 5Y- ROE-125.42% 52W Range0.30 - 3.01 Perf YTD-7.12%
Dividend Est.- P/FCF- EPS past 5Y-55.07% ROI-78.95% 52W High-87.69% Beta1.91
Dividend TTM- Quick Ratio3.22 Sales past 5Y63.37% Gross Margin53.39% 52W Low23.53% ATR (14)0.06
Dividend Ex-Date- Current Ratio3.71 EPS Y/Y TTM0.32% Oper. Margin-127.78% RSI (14)36.66 Volatility12.04% 12.51%
Employees147 Debt/Eq1.16 Sales Y/Y TTM0.27% Profit Margin-178.21% Recom1.67 Target Price4.00
Option/ShortYes / Yes LT Debt/Eq1.10 EPS Q/Q-121.26% Payout- Rel Volume0.37 Prev Close0.38
Sales Surprise-0.33% EPS Surprise-154.17% Sales Q/Q-26.32% EarningsMar 28 AMC Avg Volume760.90K Price0.37
SMA20-14.34% SMA50-18.07% SMA200-52.18% Trades Volume251,096 Change-2.47%
Today 09:00AM
Mar-28-24 11:53PM
Feb-26-24 09:15AM
08:44AM Loading…
Feb-23-24 08:44AM
Nov-13-23 05:32PM
Nov-07-23 09:00AM
Nov-03-23 12:00PM
Sep-28-23 03:48PM
Aug-29-23 04:05PM
Aug-10-23 04:51PM
Aug-03-23 05:00PM
09:05AM Loading…
Jun-08-23 09:05AM
Jun-06-23 03:00AM
Jun-05-23 05:30PM
May-31-23 05:29PM
May-23-23 09:00AM
May-22-23 12:00PM
May-18-23 10:00AM
May-15-23 09:00AM
May-13-23 08:05AM
May-12-23 04:17PM
May-11-23 05:25PM
Apr-27-23 04:05PM
Apr-17-23 07:50AM
06:47AM Loading…
Mar-31-23 09:00AM
Mar-28-23 04:59AM
Mar-25-23 08:21AM
Mar-21-23 05:25PM
Mar-16-23 06:00AM
Mar-14-23 06:00AM
Mar-09-23 04:30PM
Feb-27-23 09:00AM
Feb-16-23 09:00AM
Jan-09-23 09:00AM
Telesis Bio, Inc. engages in the provision of automated multi-omic and synthetic biology solutions. The firm also focuses on providing applications to enable researchers to rapidly, accurately, and reproducibly build or write synthetic DNA and mRNA and short oligonucleotides such as CRISPR guides that are ready to use in many downstream synthetic biology enabled markets. The company was founded by Daniel G. Gibson and J. Craig Venter on March 24, 2011 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Nelson Todd RobertPresident & CEOMay 04 '23Sale2.832,5757,277136,072May 08 08:11 PM
Gibson Daniel GlennChief Technology OfficerMay 04 '23Sale2.831,1903,363102,083May 08 08:09 PM
Cutler RobChief Legal OfficerMay 04 '23Sale2.831,1743,31825,468May 08 08:06 PM